Executive Keynote Speakers:
Stéphane Bancel joined Moderna in the summer of 2011 when it was a one-employee company. He has assembled a world-class team and raised nearly $2 billion between equity financing and upfront from licensing collaborations.
Youssef Bennani is currently VP R&D-Vertex Pharmaceuticals-Canada and Chairman of the Board of Directors at Domain Therapeutics-France and Domain Therapeutics North America-Canada.
Expert Panel Speakers:
Christophe BANCEL - CEO AT GECKO BIOMEDICAL. Christophe Bancel has a record of accomplishment in the healthcare industry ranging from startups to midsize Biopharma (UCB Pharma, Serono, Domain Therapeutics, Transgene).
Jennifer Bock is a U.S. attorney based in the Boston office of McDermott Will & Emery, an international law firm with a Paris office, among others.
Dr. Vanessa Elharrar completed her residency in Preventive Medicine and MPH at Johns Hopkins University after which she joined the Henry M. Jackson Foundation as a Medical Officer to support NIH-funded HIV prevention trials.
Dr Shahin Gharakhanian is the founder of the 1st Boston-Paris Biotechnology Summit. Shahin specializes in Drug & Vaccine Clinical Development Medical Affairs.
Sofia IOANNIDOU, Investment Director, Life Sciences Edmond de Rothschild Investment Partners. Sofia joined EdRIP in 2009 and is an Investment Director in the Life Sciences team.
Laurent Levy, PhD CEO & Nanobiotix co-founder, Laurent is a nanomedicine expert, 20 years + of experience, he co-founded Nanobiotix, a late clinical-stage nanomedicine company pioneering novel approaches for the local treatment of cancer.
Bruno Lucidi is Life Sciences Expert at Wallonia Export Investment Agency (AWEX), Expert for the European Commission Horizon 2020, Board director at Atea Inc. and Advisor to Biopharmaceutical companies and Investors.
Greg Mannix is Vice President of International Business Development at Life Science Nation. After graduating from the University of California, he moved to Europe where he began a career in the life sciences and obtained a Master’s degree from IE Business School in Madrid.
Sam MURPHY Managing Partner, BioPharma Capital, Inc.; Sam is a managing partner at BioPharma Capital, Inc., a newly formed transaction advisory firm supporting licensing, M&A, and private placements for early-stage life science companies.
Patrick focused on neuropharmacology research in academia/industry, both in France and US (1986-1990) then Synthélabo Recherche in 1991.
Julius is a Senior Consultant at Bionest Partners in Paris. Prior to joining Bionest in 2016, Julius worked for 6 years in the healthcare sector, both on the consulting and industry side.
Jacques Bernard Taste, Founder and President of Biotech Finances. After graduating from the University of Lyon, Jacques-Bernard worked for his entire career in the financial press sector.
Rafaèle Tordjman, MD, PhD, is Special Advisor for Sofinnova Partners in 2001. Prior to this, she worked as a research scientist at the Institut National de la Recherche Médicale (INSERM) in Cochin Hospital, Paris.
Maryvonne Hiance is Chairman of France Biotech, the Association of French Biotechnology and Life Sciences companies.
Mr. Pierce is passionate about helping founders transform great ideas into sustainable companies. As Founder of FEP Capital of Cambridge, Massachusetts, Mr. Pierce is an advisor, senior executive and or investor in several healthcare start-ups and public companies.